Quinlan Paul T
Insider CIK 1333277 · CBAY General Counsel · SZYM General Counsel · ORKA General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-10-20 | 2026-10-20 | 9,000 | — | $0 | 70,996 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-10-20 | 2026-10-20 | 3,000 | $79.49 | $238.5K | 29,995 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-10-20 | 2026-10-20 | 4,100 | $78.79 | $323.0K | 32,995 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-10-20 | 2026-10-20 | 1,000 | $77.20 | $77.2K | 37,095 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-10-20 | 2026-10-20 | 500 | $76.12 | $38.1K | 38,095 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-10-20 | 2026-10-20 | 400 | $74.90 | $30.0K | 38,595 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-10-20 | 2026-10-20 | 9,000 | $7.80 | $70.2K | 38,995 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-09-21 | 2026-09-21 | 10,000 | — | $0 | 79,996 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-21 | 2026-09-21 | 3,832 | $93.32 | $357.6K | 33,263 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-21 | 2026-09-21 | 601 | $94.44 | $56.8K | 32,662 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-21 | 2026-09-21 | 2,667 | $95.31 | $254.2K | 29,995 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-21 | 2026-09-21 | 2,900 | $92.37 | $267.9K | 37,095 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-09-21 | 2026-09-21 | 10,000 | $7.80 | $78.0K | 39,995 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-09-21 | 2026-09-21 | 10,000 | — | $0 | 79,996 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-21 | 2026-09-21 | 2,667 | $95.31 | $254.2K | 29,995 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-21 | 2026-09-21 | 601 | $94.44 | $56.8K | 32,662 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-21 | 2026-09-21 | 3,832 | $93.32 | $357.6K | 33,263 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-21 | 2026-09-21 | 2,900 | $92.37 | $267.9K | 37,095 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-09-21 | 2026-09-21 | 10,000 | $7.80 | $78.0K | 39,995 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-15 | 1,039 | $95.71 | $99.4K | 29,995 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-15 | 1,039 | $95.71 | $99.4K | 29,995 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-08-14 | 2026-08-14 | 42,000 | — | $0 | 120,500 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-08-14 | 2026-08-14 | 10,000 | — | $0 | 89,996 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-08-14 | 2026-08-14 | 10,000 | $7.80 | $78.0K | 41,034 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-08-14 | 2026-08-14 | 42,000 | $12.50 | $525.0K | 83,034 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 3,630 | $106.05 | $385.0K | 79,404 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 10,434 | $107.14 | $1.12M | 68,970 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 14,696 | $107.97 | $1.59M | 54,274 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 10,200 | $109.11 | $1.11M | 44,074 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 9,193 | $110.00 | $1.01M | 34,881 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 3,847 | $111.14 | $427.6K | 31,034 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-08-14 | 2026-08-14 | 42,000 | — | $0 | 120,500 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise deriv | 2026-08-14 | 2026-08-14 | 10,000 | — | $0 | 89,996 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 3,847 | $111.14 | $427.5K | 31,034 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 9,193 | $110.00 | $1.01M | 34,881 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 10,200 | $109.11 | $1.11M | 44,074 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 14,696 | $107.97 | $1.59M | 54,274 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 10,434 | $107.14 | $1.12M | 68,970 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-08-14 | 2026-08-14 | 3,630 | $106.05 | $385.0K | 79,404 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-08-14 | 2026-08-14 | 42,000 | $12.50 | $525.0K | 83,034 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | M Exercise | 2026-08-14 | 2026-08-14 | 10,000 | $7.80 | $78.0K | 41,034 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-06-15 | 2026-06-15 | 733 | $69.69 | $51.1K | 31,034 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | S Sale | 2026-03-16 | 2026-03-17 | 733 | $41.30 | $30.3K | 31,767 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2026-01-23 | 2026-01-23 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award | 2026-01-23 | 2026-01-23 | 32,500 | — | $0 | 32,500 | SEC↗ |
| ORKA Oruka Therapeutics, Inc. | A Award deriv | 2025-01-22 | 2025-01-24 | 162,500 | — | $0 | 162,500 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 107,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 233,176 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 105,625 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 215,000 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer deriv | 2024-03-22 | 2024-03-22 | 22,167 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer | 2024-03-22 | 2024-03-22 | 41,824 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | D To issuer | 2024-03-22 | 2024-03-22 | 28,438 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 41,824 | — | $0 | 8,872 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-03-13 | 2024-03-15 | 41,824 | $7.89 | $330.0K | 70,262 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2024-01-24 | 2024-01-26 | 105,625 | — | $0 | 105,625 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award | 2024-01-24 | 2024-01-26 | 28,438 | — | $0 | 28,438 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2024-01-16 | 2024-01-16 | 5,000 | — | $0 | 107,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2024-01-16 | 2024-01-16 | 5,000 | $23.58 | $117.9K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2024-01-16 | 2024-01-16 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-12-15 | 2023-12-15 | 5,000 | — | $0 | 112,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-12-15 | 2023-12-15 | 5,000 | $21.98 | $109.9K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-12-15 | 2023-12-15 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-11-15 | 2023-11-17 | 5,000 | — | $0 | 117,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-11-15 | 2023-11-17 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-11-15 | 2023-11-17 | 5,000 | $17.38 | $86.9K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-10-16 | 2023-10-18 | 5,000 | — | $0 | 122,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-10-16 | 2023-10-18 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-10-16 | 2023-10-18 | 5,000 | $13.76 | $68.8K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-09-15 | 2023-09-19 | 53,000 | — | $0 | 127,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-09-15 | 2023-09-19 | 24,000 | $2.94 | $70.6K | 24,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-09-15 | 2023-09-19 | 5,000 | $16.87 | $84.3K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-09-15 | 2023-09-19 | 24,000 | $2.94 | $70.6K | 24,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-09-15 | 2023-09-19 | 24,000 | $16.87 | $404.9K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-09-15 | 2023-09-19 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-09-15 | 2023-09-19 | 24,000 | $16.87 | $404.9K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-08-15 | 2023-08-16 | 5,000 | — | $0 | 180,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-08-15 | 2023-08-16 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-08-15 | 2023-08-16 | 5,000 | $11.91 | $59.5K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-07-14 | 2023-07-14 | 5,000 | — | $0 | 185,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-07-14 | 2023-07-14 | 5,000 | $11.81 | $59.0K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-07-14 | 2023-07-14 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-06-30 | 2023-06-30 | 5,000 | — | $0 | 190,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-06-30 | 2023-06-30 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-06-30 | 2023-06-30 | 5,000 | $10.05 | $50.3K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise deriv | 2023-05-15 | 2023-05-17 | 5,000 | — | $0 | 195,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | M Exercise | 2023-05-15 | 2023-05-17 | 5,000 | $2.94 | $14.7K | 5,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | S Sale | 2023-05-15 | 2023-05-17 | 5,000 | $10.37 | $51.8K | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2023-01-25 | 2023-01-27 | 215,000 | — | $0 | 215,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2022-01-25 | 2022-01-27 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 22,167 | — | $0 | 22,167 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2020-10-12 | 2020-10-14 | 275,000 | — | $0 | 275,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2019-01-29 | 2019-01-31 | 86,445 | — | $0 | 86,445 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 250,000 | — | $0 | 250,000 | SEC↗ |
| TVIA TerraVia Holdings, Inc. | S Sale | 2017-03-09 | 2017-03-13 | 25,000 | $0.81 | $20.3K | 218,403 | SEC↗ |
| TVIA TerraVia Holdings, Inc. | A Award deriv | 2017-02-06 | 2017-02-08 | 200,000 | — | $0 | 200,000 | SEC↗ |
| TVIA TerraVia Holdings, Inc. | A Award | 2017-02-06 | 2017-02-08 | 100,000 | — | $0 | 220,403 | SEC↗ |
| TVIA TerraVia Holdings, Inc. | A Award | 2017-02-06 | 2017-02-08 | 23,000 | — | $0 | 243,403 | SEC↗ |
| TVIA TerraVia Holdings, Inc. | S Sale | 2016-10-14 | 2016-10-14 | 10,000 | $2.55 | $25.5K | 120,403 | SEC↗ |
| TVIA TerraVia Holdings, Inc. | S Sale | 2016-09-16 | 2016-09-16 | 3,124 | $2.60 | $8.1K | 130,528 | SEC↗ |
| TVIA TerraVia Holdings, Inc. | S Sale | 2016-09-13 | 2016-09-15 | 1,562 | $2.74 | $4.3K | 133,652 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2016-03-10 | 2016-03-14 | 4,686 | $1.64 | $7.7K | 133,007 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2016-03-08 | 2016-03-09 | 350,000 | — | $0 | 350,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award | 2016-03-08 | 2016-03-09 | 62,500 | — | $0 | 137,693 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2016-03-08 | 2016-03-09 | 1,562 | $1.66 | $2.6K | 75,193 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2015-09-17 | 2015-09-17 | 1,562 | $3.14 | $4.9K | 76,755 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2015-09-15 | 2015-09-17 | 1,562 | $3.08 | $4.8K | 78,317 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2015-03-09 | 2015-03-11 | 9,687 | $2.69 | $26.1K | 79,879 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-03-03 | 2015-03-05 | 22,636 | — | $0 | 22,636 | SEC↗ |
| SZYM SOLAZYME INC | A Award | 2015-03-03 | 2015-03-04 | 25,000 | — | $0 | 89,566 | SEC↗ |
| SZYM SOLAZYME INC | F Tax w/h | 2015-03-02 | 2015-03-04 | 5,747 | $2.67 | $15.3K | 64,566 | SEC↗ |
| SZYM SOLAZYME INC | D To issuer deriv | 2015-02-19 | 2015-02-20 | 60,000 | — | $0 | 0 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-02-19 | 2015-02-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | D To issuer deriv | 2015-02-19 | 2015-02-20 | 100,000 | — | $0 | 0 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-02-19 | 2015-02-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SZYM SOLAZYME INC | D To issuer deriv | 2015-02-19 | 2015-02-20 | 50,000 | — | $0 | 0 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-02-19 | 2015-02-20 | 25,001 | — | $0 | 25,001 | SEC↗ |
| SZYM SOLAZYME INC | D To issuer deriv | 2015-02-19 | 2015-02-20 | 55,000 | — | $0 | 0 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-02-19 | 2015-02-20 | 27,500 | — | $0 | 27,500 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-02-19 | 2015-02-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SZYM SOLAZYME INC | D To issuer deriv | 2015-02-19 | 2015-02-20 | 40,000 | — | $0 | 0 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-02-19 | 2015-02-23 | 27,500 | — | $0 | 27,500 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-02-19 | 2015-02-23 | 25,001 | — | $0 | 25,001 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-02-19 | 2015-02-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-02-19 | 2015-02-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2015-02-19 | 2015-02-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2014-12-18 | 2014-12-22 | 137,500 | — | $0 | 137,500 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2014-09-09 | 2014-09-11 | 16,562 | $8.53 | $141.3K | 70,313 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2014-08-19 | 2014-08-19 | 6,000 | — | $0 | 22,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2014-08-19 | 2014-08-19 | 6,000 | $9.55 | $57.3K | 86,875 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2014-08-19 | 2014-08-19 | 6,000 | $2.35 | $14.1K | 92,875 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2014-08-15 | 2014-08-19 | 2,500 | $9.13 | $22.8K | 86,875 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2014-07-21 | 2014-07-22 | 6,000 | — | $0 | 28,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2014-07-21 | 2014-07-22 | 6,000 | $2.35 | $14.1K | 92,875 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2014-07-21 | 2014-07-22 | 6,000 | $9.80 | $58.8K | 86,875 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2014-06-19 | 2014-06-20 | 6,000 | — | $0 | 34,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2014-06-19 | 2014-06-20 | 6,000 | $11.99 | $71.9K | 86,875 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2014-06-19 | 2014-06-20 | 6,000 | $2.35 | $14.1K | 92,875 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2014-05-19 | 2014-05-19 | 6,000 | — | $0 | 40,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2014-05-19 | 2014-05-19 | 6,000 | $9.20 | $55.2K | 86,875 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2014-05-19 | 2014-05-19 | 6,000 | $2.35 | $14.1K | 92,875 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2014-04-21 | 2014-04-21 | 6,000 | — | $0 | 46,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2014-04-21 | 2014-04-21 | 6,000 | $11.33 | $68.0K | 86,875 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2014-04-21 | 2014-04-21 | 6,000 | $2.35 | $14.1K | 92,875 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2014-03-19 | 2014-03-19 | 6,000 | — | $0 | 52,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2014-03-19 | 2014-03-19 | 6,000 | $14.39 | $86.3K | 86,875 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2014-03-19 | 2014-03-19 | 6,000 | $2.35 | $14.1K | 92,875 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2014-03-04 | 2014-03-04 | 3,125 | $12.21 | $38.2K | 86,875 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2014-02-24 | 2014-02-24 | 6,000 | — | $0 | 58,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2014-02-24 | 2014-02-24 | 8,239 | $11.61 | $95.7K | 90,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2014-02-24 | 2014-02-24 | 6,000 | $2.35 | $14.1K | 98,239 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2014-02-12 | 2014-02-14 | 55,000 | — | $0 | 55,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award | 2014-02-12 | 2014-02-14 | 25,000 | — | $0 | 90,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2014-01-21 | 2014-01-22 | 6,000 | $10.47 | $62.8K | 65,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2013-12-19 | 2013-12-19 | 6,000 | $9.40 | $56.4K | 71,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2013-11-19 | 2013-11-19 | 6,000 | $8.41 | $50.5K | 77,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2013-10-21 | 2013-10-21 | 6,000 | $11.47 | $68.8K | 83,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2013-09-19 | 2013-09-19 | 6,000 | $10.73 | $64.4K | 89,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2013-08-16 | 2013-08-16 | 739 | $11.89 | $8.8K | 95,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2013-06-19 | 2013-06-21 | 3,000 | — | $0 | 64,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2013-06-19 | 2013-06-21 | 3,000 | $12.04 | $36.1K | 95,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2013-06-19 | 2013-06-21 | 3,000 | $2.35 | $7.0K | 98,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2013-05-20 | 2013-05-21 | 3,000 | — | $0 | 67,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2013-05-20 | 2013-05-21 | 3,000 | $11.17 | $33.5K | 95,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2013-05-20 | 2013-05-21 | 3,000 | $2.35 | $7.0K | 98,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2013-05-10 | 2013-05-10 | 21,000 | — | $0 | 70,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2013-05-10 | 2013-05-10 | 21,000 | $10.00 | $210.0K | 95,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2013-05-10 | 2013-05-10 | 21,000 | $2.35 | $49.4K | 116,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2013-02-25 | 2013-02-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award | 2013-02-25 | 2013-02-27 | 40,000 | — | $0 | 95,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award | 2013-02-25 | 2013-02-27 | 25,000 | — | $0 | 55,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-10-12 | 2012-10-12 | 2,000 | — | $0 | 91,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-10-12 | 2012-10-12 | 2,000 | $10.24 | $20.5K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-10-12 | 2012-10-12 | 2,000 | $2.35 | $4.7K | 32,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-09-19 | 2012-09-20 | 3,000 | — | $0 | 95,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-09-19 | 2012-09-20 | 3,000 | $2.35 | $7.0K | 33,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-09-19 | 2012-09-20 | 3,000 | $11.39 | $34.2K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-09-12 | 2012-09-13 | 2,000 | — | $0 | 96,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-09-12 | 2012-09-13 | 2,000 | $2.35 | $4.7K | 32,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-09-12 | 2012-09-13 | 2,000 | $11.44 | $22.9K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-08-20 | 2012-08-20 | 3,000 | — | $0 | 98,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-08-20 | 2012-08-20 | 3,000 | $13.17 | $39.5K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-08-20 | 2012-08-20 | 3,000 | $2.35 | $7.0K | 33,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-08-13 | 2012-08-13 | 2,000 | — | $0 | 101,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-08-13 | 2012-08-13 | 2,000 | $2.35 | $4.7K | 32,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-08-13 | 2012-08-13 | 2,000 | $11.89 | $23.8K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-07-19 | 2012-07-20 | 3,000 | — | $0 | 103,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-07-19 | 2012-07-20 | 3,000 | $2.35 | $7.0K | 33,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-07-19 | 2012-07-20 | 3,000 | $13.51 | $40.5K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-07-12 | 2012-07-12 | 2,000 | — | $0 | 106,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-07-12 | 2012-07-12 | 2,000 | $2.35 | $4.7K | 32,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-07-12 | 2012-07-12 | 2,000 | $11.42 | $22.8K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-06-12 | 2012-06-13 | 2,000 | — | $0 | 108,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-06-12 | 2012-06-13 | 2,000 | $2.35 | $4.7K | 32,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-06-12 | 2012-06-13 | 2,000 | $12.23 | $24.5K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-05-14 | 2012-05-14 | 2,000 | — | $0 | 110,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-05-14 | 2012-05-14 | 2,000 | $2.35 | $4.7K | 32,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-05-14 | 2012-05-14 | 2,000 | $10.06 | $20.1K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-04-12 | 2012-04-12 | 2,000 | — | $0 | 112,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-04-12 | 2012-04-12 | 2,000 | $2.35 | $4.7K | 32,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-04-12 | 2012-04-12 | 2,000 | $12.81 | $25.6K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-03-12 | 2012-03-13 | 2,000 | — | $0 | 114,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-03-12 | 2012-03-13 | 2,000 | $13.97 | $27.9K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-03-12 | 2012-03-13 | 2,000 | $2.35 | $4.7K | 32,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-03-02 | 2012-03-06 | 2,500 | $13.13 | $32.8K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-02-13 | 2012-02-13 | 2,000 | — | $0 | 116,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-02-13 | 2012-02-13 | 2,000 | $2.35 | $4.7K | 32,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-02-13 | 2012-02-13 | 2,000 | $11.30 | $22.6K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | A Award deriv | 2012-02-11 | 2012-02-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise deriv | 2012-01-12 | 2012-01-12 | 2,000 | — | $0 | 118,000 | SEC↗ |
| SZYM SOLAZYME INC | S Sale | 2012-01-12 | 2012-01-12 | 2,000 | $11.16 | $22.3K | 30,000 | SEC↗ |
| SZYM SOLAZYME INC | M Exercise | 2012-01-12 | 2012-01-12 | 2,000 | $2.35 | $4.7K | 32,000 | SEC↗ |